Obesity and related co-morbidities
are increasing worldwide and pose a
serious health problem. Changes in
lifestyle and diet would be the best
remedies to fight obesity; however,
many people will still rely on
medical aid. Marine organisms have
been prolific in the production of
bioactive compounds for many
diseases, e.g., cancer, and promise
to be an excellent source for
natural-derived molecules and novel
nutraceuticals. Bioactive compounds
with beneficial activities towards
obesity have been described from
diverse marine organism including
marine algae, bacteria, sponges,
fungi, crustaceans or fish.
This Special Issue will highlight
the progress in the following
topics: Bioactive compounds for the
treatment of obesity and
obesity-related co-morbidities
(diabetes, fatty liver,
hyperlipidemia) from marine
organisms; the isolation of novel
compounds, the bioactivity screening
of marine organisms and the
elucidation of molecular mode of
action of marine bioactive
compounds.